Pharm 13 Flashcards
MAOI should not be administered with SSRI’s or potent TCA’s due to development of this condition
Serotonin syndrome
Tach, sweating, dilated pupils, myoclonus, hyperreflexia, hyperthermia
Sedation is a common side effect of these drugs.
Lower seizure threshold.
Uses = BAD, acute panic attacks, phobias, enuresis, and chronic pain
Overdose = lethal
Tricyclic antidepressants (TCA)
Three C’s associated with TCA toxicity
Coma, Convulsions, Cardiac problems (arrhythmias and wide QRS)
Agents having higher sedation and antimuscarinic effects than other TCA’s
Tertiary amines
A hypnotic & TCA used in chronic pain, that has marked antimuscarinic effects
Amitriptyline
TCA with greatest sedation of this group, and marked antimuscarinic effects, used for sleep
Doxepin
TCA used in OCD.
Most significant of TCA’s for risk of seizure, weight gain, and neuropsychiatric signs and symptoms
Clomipramine
Secondary amines that have less sedation and more excitation effect
Nortriptyline, Desipramine
Antidepressant associated with neuroleptic malignant syndrome
Amoxapine
Antidepressant associated with seizures and cardiotoxicity
Maprotiline
Antidepressant having stimulant effects similar to SSRI’s and can increase blood pressure
Venlafaxine
Antidepressant inhibiting norepinephrine, serotonin, and dopamine reuptake
Venlafaxine
Antidepressant used for sleep that causes priapism
Trazodone
Antidepressant which is an inhibitor of CYP450 and may be associated with hepatic failure
Nefazodone
Antidepressant with MOA as alpha 2 antagonist, has effects on both 5-HT and NE, blocks histamine receptors, and is sedating
Mirtazapine